Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
ARGX argenx SE
- 623.820
- -2.210-0.35%
Close Dec 20 16:00 ET
- 623.820
- 0.0000.00%
Post 20:01 ET
37.30BMarket Cap-799.77P/E (TTM)
634.400High619.600Low313.19KVolume623.200Open626.030Pre Close195.81MTurnover0.52%Turnover RatioLossP/E (Static)59.80MShares644.96552wk High8.75P/B37.28BFloat Cap349.86052wk Low--Dividend TTM59.77MShs Float644.965Historical High--Div YieldTTM2.36%Amplitude17.330Historical Low625.227Avg Price1Lot Size
About argenx SE Company
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Company Profile
SymbolARGX
Company Nameargenx SE
Listing DateMay 18, 2017
Issue Price17.00
Founded2008
CEOMr. Tim Van Hauwermeiren, M. Sc.
MarketNASDAQ
Employees1148
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressLaarderhoogtweg 25
CityAmsterdam
ProvinceNoord-Holland
CountryNetherlands (the)
Zip Code1101 EB
Phone31-76-303-04-88
Websitehttp://www.argen-x.com
Company Executives
- Name
- Position
- Salary
- Tim Van Hauwermeiren, M. Sc.
- Executive Director and Chief Executive Officer
- 17.45M
- Dr. Peter Ulrichts
- Chief Scientific Officer
- --
- Karl Gubitz
- Chief Financial Officer
- 4.76M
- Karen Massey
- Chief Operating Officer
- 7.32M
- Dr. Luc Truyen, M.D.,PhD
- Chief Medical Officer
- --
- Arjen Lemmen
- Vice President, Corporate Development and Strategy
- --
- Peter K.M. Verhaeghe
- Non-Executive Chairman of the Board
- 660.33K
- Steven E. Krognes
- Independent Director
- 635.65K
- Dr. Ana Cespedes, PhD
- Independent Director
- 261.39K
- Dr. J. Donald deBethizy, PhD
- Independent Director
- 482.23K
- Dr. Pamela M. Klein, M.D.
- Independent Director
- 471.41K
- Camilla Sylvest
- Independent Director
- 365.24K
- Anthony A. Rosenberg
- Independent Director
- 476.82K
- James M. Daly
- Independent Director
- 482.23K
- Malini Moorthy
- General Counsel
- --
- Andria Wilk
- Global Head, Quality
- --